Human sVEGF R3/Flt-4 DuoSet ELISA

• Supplier: R&D Systems
• Catalog: DY349
• Category: ELISA Kit
• Prices: $649.00
• Sizes: 1 kit (for 15 Plates)
• Assay Type: Solid Phase Sandwich ELISA
• Sample Type: 100 µL
• Range: 156.00 - 10,000 pg/mL
• Format: 96-well strip plate
• Applications: ELISA
• Gene: FLT4

Product References

Cytomegalovirus impairs cytotrophoblast-induced lymphangiogenesis and vascular - Cytomegalovirus impairs cytotrophoblast-induced lymphangiogenesis and vascular

Tabata T, Petitt M, Fang-Hoover J, Rivera J, Nozawa N, Shiboski S, Inoue N, Pereira L. Am J Pathol. 2012 Nov;181(5):1540-59.

Plasma biomarkers as predictors of outcome in patients with advanced - Plasma biomarkers as predictors of outcome in patients with advanced

Llovet JM, Pena CE, Lathia CD, Shan M, Meinhardt G, Bruix J. Clin Cancer Res. 2012 Apr 15;18(8):2290-300.

Mechanism-related circulating proteins as biomarkers for clinical outcome in - Mechanism-related circulating proteins as biomarkers for clinical outcome in

Harmon CS, DePrimo SE, Raymond E, Cheng AL, Boucher E, Douillard JY, Lim HY, Kim JS, Lechuga MJ, Lanzalone S, Lin X, Faivre S. J Transl Med. 2011 Jul 25;9:120.

Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth - Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth

Sallinen H, Anttila M, Narvainen J, Koponen J, Hamalainen K, Kholova I, Heikura T, Toivanen P, Kosma VM, Heinonen S, Alitalo K, Yla-Herttuala S. Mol Ther. 2009 Feb;17(2):278-84.

Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase - Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase

Burstein HJ, Elias AD, Rugo HS, Cobleigh MA, Wolff AC, Eisenberg PD, Lehman M, Adams BJ, Bello CL, DePrimo SE, Baum CM, Miller KD. J Clin Oncol. 2008 Apr 10;26(11):1810-6.

Antitumor activity and biomarker analysis of sunitinib in patients with - Antitumor activity and biomarker analysis of sunitinib in patients with

Rini BI, Michaelson MD, Rosenberg JE, Bukowski RM, Sosman JA, Stadler WM, Hutson TE, Margolin K, Harmon CS, DePrimo SE, Kim ST, Chen I, George DJ. J Clin Oncol. 2008 Aug 1;26(22):3743-8.

Phase II trial of sunitinib in patients with metastatic colorectal cancer after - Phase II trial of sunitinib in patients with metastatic colorectal cancer after

Saltz LB, Rosen LS, Marshall JL, Belt RJ, Hurwitz HI, Eckhardt SG, Bergsland EK, Haller DG, Lockhart AC, Rocha Lima CM, Huang X, DePrimo SE, Chow-Maneval E, Chao RC, Lenz HJ. J Clin Oncol. 2007 Oct 20;25(30):4793-9.

Single-nucleotide polymorphisms and haplotypes in the VEGF receptor 3 gene and - Single-nucleotide polymorphisms and haplotypes in the VEGF receptor 3 gene and

Lee JH, Cho EY, Namkung JH, Kim E, Kim S, Shin ES, Lee JE, Yang JM. J Invest Dermatol. 2008 Jun;128(6):1599-603. Epub 2007 Dec 20.